The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD
Status:
Completed
Trial end date:
2019-01-31
Target enrollment:
Participant gender:
Summary
This trial is an investigator initiated study involving the use of the AstraZenica Aerophere
Inhaler (Glycopyrrolate/Formoterol) to determine the effect on exercise tolerance and dynamic
hyperinflation in patients with chronic obstructive lung disease.
Phase:
Phase 4
Details
Lead Sponsor:
Los Angeles Biomedical Research Institute Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center